New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer

被引:12
|
作者
Chiaradonna, Ferdinando [1 ,2 ]
Cirulli, Claudia [1 ,2 ]
Palorini, Roberta [1 ,2 ]
Votta, Giuseppina [1 ,2 ]
Alberghina, Lilia [1 ,2 ]
机构
[1] SYSBIO Ctr Syst Biol, Milan, Italy
[2] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy
关键词
TRANSCRIPTION FACTOR YY1; DEPENDENT PROTEIN-KINASE; ACUTE MYELOID-LEUKEMIA; YIN YANG 1; C-MYC; TUMOR-SUPPRESSOR; LYSINE ACETYLATION; PYRUVATE-KINASE; SKELETAL-MUSCLE; GENE-EXPRESSION;
D O I
10.1089/ars.2014.5854
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Histone deacetylases (HDACs) activity and cell metabolism are considered important targets for cancer therapy, as both are deregulated and associated with the onset and maintenance of tumors. Recent Advances: Besides the classical function of HDACs as HDAC enzymes controlling the transcription, it is becoming increasingly evident that these proteins are involved in the regulation of several other cellular processes by their ability to deacetylate hundreds of proteins with different functions in both the cytoplasm and the nucleus. Importantly, recent high-throughput studies have identified as important target proteins several enzymes involved in different metabolic pathways. Conversely, it has been also shown that metabolic intermediates may control HDACs activity. Consequently, the acetylation/deacetylation of metabolic enzymes and the ability of metabolic intermediates to modulate HDACs may represent a cross-talk connecting cell metabolism, transcription, and other HDACs-controlled processes in physiological and pathological conditions. Critical Issues: Since metabolic alterations and HDACs deregulation are important cancer hallmarks, disclosing connections among them may improve our understanding on cancer mechanisms and reveal novel therapeutic protocols against this disease. Future Directions: High-throughput metabolic studies performed by using more sophisticated technologies applied to the available models of conditional deletion of HDACs in cell lines or in mice will fill the gap in the current understanding and open directions for future research. Antioxid. Redox Signal. 23, 30-50.
引用
收藏
页码:30 / 50
页数:21
相关论文
共 50 条
  • [1] Histone deacetylases and cancer
    Barneda-Zahonero, Bruna
    Parra, Maribel
    MOLECULAR ONCOLOGY, 2012, 6 (06) : 579 - 589
  • [2] Histone deacetylases and cancer
    M A Glozak
    E Seto
    Oncogene, 2007, 26 : 5420 - 5432
  • [3] Histone deacetylases and cancer
    Glozak, M. A.
    Seto, E.
    ONCOGENE, 2007, 26 (37) : 5420 - 5432
  • [4] Unravelling the connection between metabolism, cell growth and cancer
    Draganescu, C.
    Jacobsen, L.
    Hindie, E.
    Baillet, G.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2015, 39 (01): : 59 - 63
  • [5] New Insights into the Role of Histone Deacetylases as Coactivators of Inflammatory Gene Expression
    Schmitz, Michael Lienhard
    de la Vega, Laureano
    ANTIOXIDANTS & REDOX SIGNALING, 2015, 23 (01) : 85 - 98
  • [6] Class I histone deacetylases and energy metabolism: new players in 'diabesity'?
    Crestani, M.
    Galmozzi, A.
    Mitro, N.
    Ferrari, A.
    Gers, E.
    Gilardi, F.
    Cermenati, G.
    Caruso, D.
    Mai, A.
    Saez, E.
    De Fabiani, E.
    FEBS JOURNAL, 2011, 278 : 177 - 177
  • [7] Interplay between histone deacetylases and autophagy - from cancer therapy to neurodegeneration
    Truee, Oliver
    Matthias, Patrick
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (01): : 78 - 84
  • [8] The role of histone deacetylases in prostate cancer
    Abbas, Ata
    Gupta, Sanjay
    EPIGENETICS, 2008, 3 (06) : 300 - 309
  • [9] Histone deacetylases and cancer: Causes and therapies
    Marks, PA
    Rifkind, RA
    Richon, VM
    Breslow, R
    Miller, T
    Kelly, WK
    NATURE REVIEWS CANCER, 2001, 1 (03) : 194 - 202
  • [10] Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
    Hassell, Kelly N.
    DISEASES, 2019, 7 (04)